X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38214) 38214
Newsletter (527) 527
Magazine Article (154) 154
Newspaper Article (39) 39
Book Chapter (35) 35
Conference Proceeding (22) 22
Book / eBook (20) 20
Publication (7) 7
Transcript (6) 6
Book Review (5) 5
Dissertation (5) 5
Journal / eJournal (3) 3
Reference (2) 2
Web Resource (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30230) 30230
staphylococcal infections - microbiology (18750) 18750
female (14723) 14723
male (14021) 14021
staphylococcus aureus (11447) 11447
microbiology (10601) 10601
animals (9649) 9649
infectious diseases (9114) 9114
staphylococcal infections - drug therapy (9050) 9050
adult (7870) 7870
middle aged (7793) 7793
staphylococcal infections - epidemiology (7157) 7157
staphylococcus aureus - isolation & purification (6956) 6956
staphylococcus aureus - drug effects (6893) 6893
aged (6215) 6215
anti-bacterial agents - therapeutic use (6071) 6071
anti-bacterial agents - pharmacology (5596) 5596
microbial sensitivity tests (5555) 5555
infections (5242) 5242
methicillin resistance (5022) 5022
staphylococcal infections (4694) 4694
staphylococcal infections - diagnosis (4494) 4494
methicillin-resistant staphylococcus aureus - isolation & purification (4313) 4313
health aspects (3914) 3914
adolescent (3862) 3862
immunology (3843) 3843
staphylococcus aureus - genetics (3769) 3769
infection (3756) 3756
child (3607) 3607
staphylococcus aureus infections (3579) 3579
risk factors (3493) 3493
mrsa (3326) 3326
prevalence (3300) 3300
cross infection - microbiology (3250) 3250
staphylococcal infections - prevention & control (3154) 3154
antibiotics (3140) 3140
mice (3112) 3112
pharmacology & pharmacy (3098) 3098
epidemiology (3087) 3087
retrospective studies (2933) 2933
bacteria (2847) 2847
drug resistance in microorganisms (2794) 2794
aged, 80 and over (2787) 2787
methicillin-resistant staphylococcus aureus (2785) 2785
staphylococcal infections - complications (2770) 2770
methicillin-resistant staphylococcus aureus - drug effects (2740) 2740
child, preschool (2689) 2689
staphylococcal infections - veterinary (2627) 2627
treatment outcome (2612) 2612
research (2611) 2611
staphylococcus infections (2610) 2610
infant (2583) 2583
surgery (2453) 2453
analysis (2439) 2439
research article (2359) 2359
bacteremia (2324) 2324
strains (2286) 2286
staphylococcus - isolation & purification (2245) 2245
methicillin-resistant staphylococcus aureus - genetics (2209) 2209
virulence (2190) 2190
staphylococcus aureus - pathogenicity (2188) 2188
cross infection - epidemiology (2145) 2145
staphylococcal infections - etiology (2116) 2116
infant, newborn (2059) 2059
vancomycin (2030) 2030
hospitals (2020) 2020
bacteremia - microbiology (2019) 2019
drug resistance (2000) 2000
bacterial proteins - genetics (1996) 1996
biochemical phenomena, metabolism, and nutrition (1988) 1988
staphylococcal infections - immunology (1908) 1908
methicillin-resistant (1885) 1885
young adult (1835) 1835
anti-bacterial agents - administration & dosage (1834) 1834
colonization (1811) 1811
nosocomial infections (1794) 1794
staphylococcus aureus - classification (1778) 1778
disease models, animal (1771) 1771
community-acquired infections - microbiology (1757) 1757
staphylococcus (1753) 1753
cattle (1723) 1723
identification (1703) 1703
bacterial infections and mycoses (1698) 1698
genotype (1669) 1669
prospective studies (1667) 1667
carrier state - microbiology (1651) 1651
mortality (1648) 1648
aureus (1625) 1625
drug resistance, bacterial (1589) 1589
genes (1588) 1588
time factors (1572) 1572
infectious disease (1539) 1539
medicine (1519) 1519
staphylococcal infections - pathology (1509) 1509
skin (1504) 1504
pediatrics (1492) 1492
medicine, general & internal (1484) 1484
diagnosis (1481) 1481
staphylococcus - drug effects (1481) 1481
veterinary sciences (1468) 1468
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (10) 10
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Periodical Stacks (2) 2
Gerstein Science - Bindery (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (35469) 35469
Russian (781) 781
Spanish (622) 622
French (607) 607
Japanese (595) 595
German (491) 491
Polish (194) 194
Chinese (148) 148
Italian (106) 106
Dutch (94) 94
Turkish (88) 88
Danish (66) 66
Ukrainian (51) 51
Portuguese (50) 50
Norwegian (36) 36
Hungarian (34) 34
Romanian (34) 34
Czech (31) 31
Swedish (31) 31
Finnish (14) 14
Korean (14) 14
Croatian (13) 13
Bulgarian (11) 11
Hebrew (11) 11
Serbian (9) 9
Slovak (9) 9
Lithuanian (3) 3
Greek (2) 2
Icelandic (2) 2
Arabic (1) 1
Armenian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal
American Journal of Emergency Medicine, ISSN 0735-6757, 2017, Volume 35, Issue 4, pp. 579 - 583
...) from gram-positive (GP) bloodstream infections and determining the relationship between PCT levels, infection sites, and pathogen types... 
Emergency | Positive blood culture | Procalcitonin | Bacterial species | Gram-positive bacteria | Sepsis | Gram-negative bacteria | Infection sites | DIAGNOSIS | MANAGEMENT | ANTIBIOTIC USE | GUIDELINES | MARKERS | CALCITONIN | EMERGENCY MEDICINE | SEPTIC SHOCK | SERUM PROCALCITONIN | RESPIRATORY-TRACT INFECTIONS | Enterococcus faecalis | Escherichia coli | Humans | Middle Aged | Escherichia coli Infections - blood | Male | Acinetobacter Infections - blood | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Endocarditis, Bacterial - blood | Staphylococcus haemolyticus | Burkholderia cepacia | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Staphylococcal Infections - microbiology | Klebsiella Infections - blood | Burkholderia Infections - microbiology | Staphylococcal Infections - blood | Staphylococcus aureus | Acinetobacter Infections - microbiology | Pneumonia, Bacterial - blood | Calcitonin - blood | Emergency Service, Hospital | Intensive Care Units | Pneumonia, Bacterial - microbiology | Escherichia coli Infections - microbiology | Biomarkers - blood | Klebsiella Infections - microbiology | Gram-Positive Bacterial Infections - blood | Enterococcus faecium | Staphylococcus hominis | Acinetobacter baumannii | Urinary Tract Infections - blood | Staphylococcus epidermidis | Catheter-Related Infections - blood | Catheter-Related Infections - microbiology | Gram-Negative Bacterial Infections - blood | Aged | Burkholderia Infections - blood | Klebsiella pneumoniae | Bacteria | Health aspects | Medical research | Medical examination | Microbiology | Emergency medicine | Analysis | Endocarditis | Medicine, Experimental | Urinary tract infections | Blood | Lupus | Klebsiella | Pathogens | Multiple sclerosis | Intensive care | Pneumonia | Bacterial infections | Disease | Laboratories | Lung cancer | Medical instruments | Infections | Arthritis | Family medical history | Urinary tract | Patients | Microorganisms | Thyroid cancer | Biomarkers | Cutoffs | Diagnostic systems
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy
Journal Article
Burns, ISSN 0305-4179, 2017, Volume 43, Issue 3, pp. 642 - 653
Highlights • Burn depth/agent increases risk of developing an infection. • Infections found folliculitis, burn wound, urinary tract, pneumonia, CVC and bloodstream... 
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | URINARY-TRACT-INFECTION | MORTALITY | SURGERY | RISK-FACTORS | DERMATOLOGY | REPLACEMENT | BACTERIOLOGY | CATHETERS | INTENSIVE-CARE-UNIT | SURVEILLANCE | ASSOCIATION | BLOOD-STREAM INFECTIONS | CRITICAL CARE MEDICINE | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 2014, Volume 210, Issue 9, pp. 1357 - 1366
Background. Limitations in treatment of biofilm-associated bacterial infections are often due to subpopulation of persistent bacteria (persisters... 
Biofilms | Antibiotics | Escherichia coli | Bacteria | Aminoglycosides | Pseudomonas aeruginosa | Infections | Basic amino acids | Staphylococcus aureus | aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | DIAGNOSIS | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | TOLERANCE | SUSCEPTIBILITY | MICROBIOLOGY | IMMUNOLOGY | ANTIBIOTIC-LOCK THERAPY | GENTAMICIN | PSEUDOMONAS-AERUGINOSA | L-ARGININE | GROWTH | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2009, Volume 34, Issue 1, pp. S2 - S7
Abstract Skin and soft tissue infections (SSTIs) are common and range in severity from minor, self-limiting, superficial infections to life-threatening diseases requiring all the resources of modern medicine... 
Infectious Disease | Community-acquired infections | Hospital infections | Staphylococci | Skin and soft tissue infections | Meticillin-resistant Staphylococcus aureus | Risk factors | Aetiology | INFECTIOUS DISEASES | ANTIBIOTICS | MANAGEMENT | PASTEURELLA-MULTOCIDA | GUIDELINES | MICROBIOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | WOUND INFECTIONS | COMMUNITY | PANTON-VALENTINE LEUKOCIDIN | SURVEILLANCE | PHARMACOLOGY & PHARMACY | TOXIC-SHOCK-SYNDROME | Streptococcal Infections - microbiology | Skin Diseases, Bacterial - microbiology | Community-Acquired Infections - epidemiology | Staphylococcal Skin Infections - epidemiology | Bacterial Infections - drug therapy | Humans | Streptococcal Infections - epidemiology | Soft Tissue Infections - epidemiology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Skin Diseases, Bacterial - epidemiology | Streptococcus - isolation & purification | Cross Infection - microbiology | Bacterial Infections - epidemiology | Staphylococcal Infections - microbiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Bacterial Infections - microbiology | Cross Infection - epidemiology | Cross infection | Nosocomial infections | Microbiology | Health aspects | Epidemiology | Staphylococcus aureus infections
Journal Article
Burns, ISSN 0305-4179, 2017, Volume 43, Issue 1, pp. 144 - 148
Highlights • Gram-positive organisms accounted for 66.4% of the causative pathogens for bloodstream infections (BSIs... 
Critical Care | Burn | Pediatric burn patients | Burn-associated bloodstream infections | Children | SURGERY | Burn-associated bloodstream | PERFORMANCE | COLONIZATION | SKIN CULTURES | IDENTIFICATION | DERMATOLOGY | VITEK 2 | infections | SURVEILLANCE | CRITICAL CARE MEDICINE | Anti-Infective Agents - pharmacology | Humans | Candidiasis - epidemiology | Child, Preschool | Infant | Male | Candidiasis - microbiology | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Klebsiella Infections - epidemiology | Time Factors | Gram-Positive Bacterial Infections - microbiology | Female | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Acinetobacter Infections - microbiology | Central Venous Catheters | Risk Factors | Burns - microbiology | Escherichia coli Infections - microbiology | Catheterization, Central Venous | Klebsiella Infections - microbiology | Fungemia - microbiology | Pseudomonas Infections - microbiology | Burns - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Turkey - epidemiology | Acinetobacter Infections - epidemiology | Catheter-Related Infections - microbiology | Adolescent | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | Fungemia - epidemiology | Pediatrics | Burns and scalds | Health aspects | Diseases
Journal Article
Journal of Preventive Medicine and Hygiene, ISSN 1121-2233, 2017, Volume 58, Issue 4, pp. E294 - E301
National efforts to curtail healthcare-associated infections (HAI) proliferated recently, though data detailing progress over time are limited... 
Bloodstream infections | Urinary tract infections | Antimicrobial resistance | Multidrug-resistant organisms | Surgical site infections | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Incidence | Gram-Negative Bacterial Infections - microbiology | Young Adult | Gram-Positive Bacterial Infections - microbiology | Urinary Tract Infections - microbiology | Odds Ratio | Staphylococcus aureus | Enterococcus | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Logistic Models | Pseudomonas Infections - microbiology | Gram-Positive Bacterial Infections - epidemiology | Streptococcus pneumoniae | Acinetobacter baumannii | Cross Infection - microbiology | Adolescent | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | New York City - epidemiology | Surgical Wound Infection - microbiology | Gram-Positive Bacterial Infections - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Surgical Wound Infection - drug therapy | Adult | Female | Pseudomonas aeruginosa | Retrospective Studies | Staphylococcal Infections - microbiology | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | Streptococcal Infections - microbiology | Staphylococcal Infections - drug therapy | Surgical Wound Infection - epidemiology | Klebsiella Infections - drug therapy | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Streptococcal Infections - epidemiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Streptococcal Infections - drug therapy | Aged | Klebsiella pneumoniae
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2019, Volume 63, Issue 7
Bloodstream infection (BSI) organisms were consecutively collected from >200 medical centers in 45 nations between 1997 and 2016... 
NETWORK | CARE-ASSOCIATED INFECTIONS | ESCHERICHIA-COLI | VACCINE | MICROBIOLOGY | bloodstream infection | RESISTANT STAPHYLOCOCCUS-AUREUS | METHICILLIN-RESISTANT | antimicrobial resistance | BACTEREMIA | PHARMACOLOGY & PHARMACY | surveillance | ENGLAND | ENTEROBACTERIACEAE | HISTORY | Klebsiella pneumoniae - isolation & purification | Pseudomonas aeruginosa - isolation & purification | Enterococcus faecalis - drug effects | Klebsiella pneumoniae - drug effects | Community-Acquired Infections - epidemiology | Humans | Bacteremia - microbiology | Microbial Sensitivity Tests | Klebsiella Infections - epidemiology | Gram-Positive Bacterial Infections - microbiology | Acinetobacter baumannii - isolation & purification | Staphylococcal Infections - microbiology | Drug Resistance, Bacterial - drug effects | Acinetobacter Infections - microbiology | Latin America - epidemiology | Staphylococcus aureus - isolation & purification | Europe - epidemiology | Klebsiella Infections - microbiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Gram-Positive Bacterial Infections - epidemiology | Enterococcus faecalis - isolation & purification | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Staphylococcus aureus - drug effects | Community-Acquired Infections - microbiology
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2015, Volume 61, Issue suppl 2, pp. S69 - S78
Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality among hospitalized patients and a major therapeutic challenge for clinicians... 
telavancin | necrotizing infections | skin infections | cellulitis | soft-tissue infections | UNITED-STATES | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RISK-FACTORS | NECROTIZING FASCIITIS | CARE-ASSOCIATED INFECTIONS | MICROBIOLOGY | IMMUNOLOGY | COMPLICATED SKIN | STREPTOCOCCAL INFECTIONS | STAPHYLOCOCCUS-AUREUS INFECTIONS | SURGICAL SITE INFECTION | EPIDEMIOLOGY | Skin Diseases, Bacterial - microbiology | Humans | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Gram-Positive Bacterial Infections - microbiology | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | Soft Tissue Infections - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Daptomycin - pharmacology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Oxazolidinones - pharmacology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | North America - epidemiology | Aminoglycosides - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Aminoglycosides - therapeutic use
Journal Article
Clinical orthopaedics and related research, ISSN 1528-1132, 2013, Volume 471, Issue 7, pp. 2383 - 2399
Staphylococcus aureus is the most common organism responsible for orthopaedic surgical site infections (SSIs... 
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Orthopedics | Surgery | Conservative Orthopedics | Medicine/Public Health, general | SURGERY | COST-EFFECTIVENESS | HOSPITAL STAFF | ACTIVE SURVEILLANCE | MRSA | ERADICATION | OF-THE-LITERATURE | ORTHOPEDICS | NASAL CARRIAGE | INTRANASAL MUPIROCIN | WOUND INFECTIONS | NOSOCOMIAL INFECTIONS | Community-Acquired Infections - diagnosis | Community-Acquired Infections - therapy | Community-Acquired Infections - transmission | Hospital Costs | Cross Infection - economics | Humans | Orthopedic Procedures - adverse effects | Infection Control - methods | Cost Savings | Cross Infection - transmission | Staphylococcal Infections - microbiology | Surgical Wound Infection - transmission | Cross Infection - prevention & control | Mass Screening - economics | Community-Acquired Infections - economics | Surgical Wound Infection - economics | Anti-Infective Agents - therapeutic use | Treatment Outcome | Staphylococcal Infections - therapy | Staphylococcal Infections - transmission | Surgical Wound Infection - prevention & control | Staphylococcal Infections - diagnosis | Staphylococcal Infections - economics | Cost-Benefit Analysis | Cross Infection - microbiology | Surgical Wound Infection - diagnosis | Cross Infection - diagnosis | Orthopedic Procedures - economics | Staphylococcal Infections - prevention & control | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Program Evaluation | Surgical Wound Infection - microbiology | Community-Acquired Infections - microbiology | Infection Control - economics | Online health care information services | Orthopedic surgery | Health aspects | Analysis | Staphylococcal infections | Staphylococcus aureus | Survey
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2010, Volume 51, Issue S2, pp. S183 - S197
...) has undergone rapid evolutionary changes and epidemiologic expansion to become a major cause of nosocomial and community-acquired infections worldwide... 
Osteomyelitis | Infectious diseases | Antibiotics | Antimicrobials | Endocarditis | Abscesses | Methicillin resistant staphylococcus aureus | Infections | Staphylococcus aureus | Bacteremia | HEALTH-CARE SETTINGS | INFECTIOUS DISEASES | ANTIMICROBIAL THERAPY | LINEZOLID PNU-100766 | TRANSESOPHAGEAL ECHOCARDIOGRAPHY | CLINDAMYCIN TREATMENT | MICROBIOLOGY | IMMUNOLOGY | INTRANASAL MUPIROCIN | COMPLICATED SKIN | 2 DOUBLE-BLIND | SKIN-STRUCTURE INFECTIONS | NOSOCOMIAL PNEUMONIA | Community-Acquired Infections - diagnosis | Staphylococcal Infections - pathology | Humans | Osteomyelitis - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Cross Infection - pathology | Endocarditis, Bacterial - pathology | Community-Acquired Infections - drug therapy | Osteomyelitis - pathology | Endocarditis, Bacterial - microbiology | Staphylococcal Infections - microbiology | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Bacteremia - drug therapy | Endocarditis, Bacterial - diagnosis | Bacteremia - diagnosis | Cross Infection - drug therapy | Staphylococcal Infections - diagnosis | Osteomyelitis - diagnosis | Community-Acquired Infections - pathology | Osteomyelitis - microbiology | Cross Infection - microbiology | Cross Infection - diagnosis | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Bacteremia - pathology | Community-Acquired Infections - microbiology
Journal Article